Clinical Trials Logo

Filter by:
NCT ID: NCT05202262 Not yet recruiting - Asthma Clinical Trials

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)

VATHOS
Start date: January 12, 2022
Phase: Phase 3
Study type: Interventional

This is a 24 week study to evaluate the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma.

NCT ID: NCT05197426 Not yet recruiting - Clinical trials for Acute Myeloid Leukemia

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

Start date: January 28, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in a cohort of Japanese participants ≥ 55 years of age with Acute Myeloid Leukemia (AML) and in complete remission/complete remission with incomplete blood count recovery after conventional induction chemotherapy with or without consolidation chemotherapy.

NCT ID: NCT05193136 Recruiting - COPD Clinical Trials

Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

Start date: December 10, 2021
Phase:
Study type: Observational

We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients, and clarify the effects of sleep hygiene on disease progression and life prognosis.

NCT ID: NCT05192174 Not yet recruiting - Solid Tumor Clinical Trials

Study of NIB101 in Participants With Advanced Solid Tumors

Start date: January 25, 2022
Phase: Phase 1
Study type: Interventional

NIB101-01 study is an open-label, non-randomized Phase 1 study in participants with GM2 positive advanced solid tumor, who failed to available standard of cares to evaluate the safety and tolerability of NIB101.

NCT ID: NCT05188976 Recruiting - Respiratory Disease Clinical Trials

Assessment of End-tidal Carbon Dioxide Levels in Respiratory Disease

Start date: December 1, 2021
Phase:
Study type: Observational

We aim to evaluate the correlation between PetCO2, PaCO2, and PtcCO2 in patients with respiratory diseases. We also evaluate the correlation between PetCO2, PaCO2, and PtcCO2 changes over time.

NCT ID: NCT05177029 Recruiting - Healthy Volunteers Clinical Trials

Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants

Start date: November 26, 2021
Phase: Phase 1
Study type: Interventional

The main goal of this study is to evaluate the effect of Lu AG06466 on the body and what the body does to Lu AG06466 after single and multiple doses to healthy Japanese and Caucasian participants.

NCT ID: NCT05172037 Recruiting - Covid19 Clinical Trials

Phase III Study of Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Start date: October 28, 2021
Phase: Phase 3
Study type: Interventional

An Adaptive, Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Aerosolized JH509 vs. Placebo in Non-hospitalized Adult Patients with Mild COVID-19

NCT ID: NCT05169333 Recruiting - Clinical trials for Cardiovascular Diseases

The Oxford Risk Factors And Non-Invasive Imaging Study

ORFAN
Start date: February 23, 2016
Phase:
Study type: Observational [Patient Registry]

ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.

NCT ID: NCT05167825 Not yet recruiting - Clinical trials for Pulmonary Arterial Hypertension

A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Start date: March 31, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.

NCT ID: NCT05167773 Recruiting - Clinical trials for Intraocular Pressure

Clinical Study of the Topcon Tonometer TRK-3

Start date: October 11, 2021
Phase:
Study type: Observational

The study will assess the TRK-3 for conformity to ISO 8612:2009, JIS T7312:2015, and ANSI Z80.10-2014 Ophthalmic Instruments - Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and the applicable Supplemental Information Sheet.